Controversies In Diabetic Neuropathy

<p>Introduction: 　David Tomlinson (editor of first edition) "Back in my day…."</p> <U> <p>Fit the First: Clinical Context </p></U> <p>Calcutt and Fernyhough: "An introduction to the history and controversies of clinical trials in diabetic neuropathy" </p> <p>Pop-Busui: "Neuropathy in the DCCT/EDIC - what was done then and what we would do better now" </p> <p>Bril: "The perfect　clinical trial" </p> <U> <p>Fit the Second: New Models of Diabetic Neuropathy</p></U> <p>Calcutt and Fernyhough: "An Introduction to the history and controversies of animal models of diabetic neuropathy" </p> <p>Gardiner and Freeman: "Can diabetic neuropathy be modeled in vitro?" </p> <p>Yorek: "Alternatives to the streptozotocin-diabetic rodent" </p> <U> <p>Fit the Third: Mechanisms and Therapies </p></U> <p>Fernyhough and Calcutt: "An introduction to the history and controversies of the pathogenesis of diabetic neuropathy" </p> <p>Yagihashi: "Glucotoxic mechanisms and related therapeutic approaches" </p> <p>Zochodne: "Sensory neurodegeneration in diabetes: beyond glucotoxicity<U> </U>" </p> <p>Dobrowsky: "Promoting Neuronal Tolerance of Diabetic Stress: Modulating Molecular Chaperones "</p> <p>Todorovic: "Painful diabetic neuropathy: Prevention or suppression?" </p> <U> <p>Fit the Fourth: Translating Science into Medicine</p></U> <p>Fernyhough and Calcutt: "New Directions in Diabetic Neuropathy: Evolution or Extinction?"</p> <p>Vinik, Casellini and Névoret: "Alternative Quantitative Tools in the assessment of diabetic peripheral and autonomic neuropathy" </p> <p>Malik: "Wherefore art thou, O Treatment for Diabetic Neuropathy?"</p>